CARLSBAD, Calif. , March 5, 2024 /PRNewswire/ — Today, Limmi – an AI startup dedicated to transforming patient outcomes by rapidly discovering hidden patterns in life sciences data – announced that Professor of Urology at UC San Diego Health, Dr. A. Karim Kader, MD, PhD, FRCSC has joined the company’s Advisory Board as Chairman. In addition to Dr. Kader’s impressive work at UCSD, he also spent 15 years successfully building Stratify Genomics – a biotech company founded to commercialize genetic tests to determine a patient’s risk of developing prostate cancer.
Originally published at https://www.prnewswire.com/news-releases/limmi-appoints-nationally-recognized-cancer-researcher-dr-kader-to-its-board-of-directors-302079887.html
Images courtesy of https://pixabay.com
